Knowledge Hub

Scrutinize the Global Chronic Lymphocytic Leukemia Market 2016-2020

Press Release   •   Feb 21, 2017 04:25 EST

MarketResearchReports.Biz has announced addition of new report “Global Chronic Lymphocytic Leukemia Market 2016-2020” to its database.

About the Chronic Lymphocytic Leukemia (CLL) Therapeutics Market

Cancer that starts from the hematopoietic stem cells of the bone-marrow is referred to as leukemia. Leukemia can be chronic or acute depending on the maturity of the cells. In addition, based on the bone marrow cells from which the cancer starts, leukemia can be categorized as lymphocytic or myeloid. Hence, leukemia can be broadly classified into four types:

Acute myeloid (or myelogenous) leukemia (AML)

Chronic myeloid (or myelogenous) leukemia (CML)

Acute lymphocytic (or lymphoblastic) leukemia (ALL)


Technavios analysts forecast the global CLL therapeutics market to grow at a CAGR of 19.16% during the period 2016-2020.

Click here to know more details about this report:

Covered in this report

The report covers the present scenario and the growth prospects of the global CLL therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent CLL. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:




Technavio's report, Global Chronic Lymphocytic Leukemia (CLL) Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

F. Hoffman-La Roche


Teva Pharmaceuticals

Gilead Sciences


Johnson & Johnson

Other prominent vendors

Altor BioScience


Arno Therapeutics


Bellicum Pharmaceuticals



Boston Biomedical


Emergent BioSolutions


iDD biotech


Infinity Pharmaceuticals

Innate Pharma

Karyopharm Therapeutics

Ligand Pharmaceuticals


Merck Sharp & Dohme

Molecular Templates Inc.


Ono Pharmaceutical

Portola Pharmaceuticals

Regeneron Pharmaceuticals

Sunesis Pharmaceuticals

TG Therapeutics


XEME Biopharma



Market driver

Special regulatory designations

For a full, detailed list, view our report

Market challenge

High cost of therapy

For a full, detailed list, view our report

Market trend

Rise in development of combination therapies

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Request a sample copy of this report:

About Us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Latest Industry Press Release

Contact Us

State Tower

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-621-2074



Follow us on LinkedIn: